
US Tariffs on Chinese Imports Over Fentanyl: A Misguided Strategy
The US’s recent tariffs on Chinese imports to combat fentanyl are seen as a strategic miscalculation that overlooks deeper domestic issues.
News for people and friends
The US’s recent tariffs on Chinese imports to combat fentanyl are seen as a strategic miscalculation that overlooks deeper domestic issues.
Chinese Consul General Zhang Jianmin criticizes U.S. tariffs on Chinese imports, calling them an unfair use of the fentanyl issue, and urges for respectful dialogue.
China urges the U.S. to choose cooperation over confrontation regarding the fentanyl crisis, stressing that pressure and blame are not solutions, and calls for dialogue based on mutual respect.
Tariffs aren’t the solution to America’s fentanyl crisis. The root causes lie within domestic issues, and cooperation—not tariffs—is needed to tackle this growing epidemic.
The US administration’s new tariffs on China, citing fentanyl issues, may harm both the US and global economies, experts warn, emphasizing that unilateral actions could backfire.
China expresses strong opposition to new U.S. tariffs imposed over fentanyl issues, emphasizing strict drug control policies and urging the U.S. to address its own root causes of the crisis.
Unilateral trade measures by the U.S. won’t solve the fentanyl crisis. Discover why international cooperation and addressing domestic issues are key to tackling the problem.
Experts argue that U.S. tariffs on China over fentanyl not only breach WTO rules but also hinder effective cooperation in combating the opioid crisis.
China and the US are enhancing cooperation to combat the fentanyl crisis, addressing obstacles to curb opioid abuse and save lives.
Donald Trump’s proposed tariffs on key trading partners aim to address migration and drug trafficking but risk worsening global issues. Collaborative solutions may be more effective than trade penalties.